1. |
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus [J]. Ann Surg, 1995; 222(3): 339-350.
|
2. |
Pories WJ. Diabetes: the evolution of a new paradigm [J]. Ann Surg, 2004; 239(1): 12-13.
|
3. |
Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis [J]. Diabetes Care, 2008; 31 Suppl 2: S290-S296.
|
4. |
Sjstrm L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery [J]. N Engl J Med, 2004; 351(26): 2683-2693.
|
5. |
Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity [J]. Obes Surg, 2007; 17(2): 176-184.
|
6. |
Meneghini LF. Impact of bariatric surgery on type 2 diabetes [J]. Cell Biochem Biophys, 2007; 48(2-3): 97-102.
|
7. |
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus [J]. Ann Surg, 2003; 238(4): 467-484.
|
8. |
Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3-60 month follow-up [J]. Obes Surg, 2000; 10(3): 233-239.
|
9. |
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [J]. JAMA, 2004; 292(14): 1724-1737.
|
10. |
Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids [J]. Diabetologia, 1997; 40(5): 599-605.
|
11. |
Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type Ⅱ: results in the first 10 cases [J]. Obes Surg, 1998; 8(1): 67-72.
|
12. |
Schwarz A, Büchler M, Usinger K, et al. Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study [J]. World J Surg, 1996; 20(1): 60-66.
|
13. |
Pories WJ, Albrecht RJ. Etiology of type Ⅱ diabetes mellitus: role of the foregut [J]. World J Surg, 2001; 25(4): 527-531.
|
14. |
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery [J]. N Engl J Med, 2007; 357(8): 753-761.
|
15. |
Kannel WB, McGee DL. Diabetes and cardiovascular disea-se. The Framingham study [J]. JAMA, 1979; 241(19): 2035-2038.
|
16. |
Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size [J]. JAMA, 2004; 292(7): 847-851.
|
17. |
Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13 871 morbidly obese patients from a national registry [J]. Ann Surg, 2007; 246(6): 1002-1007.
|
18. |
Nguyen NT, Hinojosa M, Fayad C, et al. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers [J]. J Am Coll Surg, 2007; 205(2): 248-255.
|
19. |
Han SH, Gracia C, Mehran A, et al. Improved outcomes us-ing a systematic and evidence-based approach to the laparoscopic Roux-en-Y gastric bypass in a single academic institution [J]. Am Surg, 2007; 73(10): 955-958.
|
20. |
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes [J]. Ann Surg, 2006; 244(5): 741-749.
|
21. |
Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery [J]. Obes Surg, 1999; 9(3): 223-228.
|
22. |
Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model [J]. Obes Surg, 2005; 15(9): 1258-1264.
|
23. |
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus [J]. Ann Surg, 2002; 236(5): 554-559.
|
24. |
Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism [J]. Ann Surg, 2004; 240(2): 236-242.
|
25. |
le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters [J]. Ann Surg, 2006; 243(1): 108-114.
|
26. |
Suzuki S, Ramos EJ, Goncalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model [J]. Surgery, 2005; 138(2): 283-290.
|
27. |
Morínigo R, Lacy AM, Casamitjana R, et al. GLP-1 and ch-anges in glucose tolerance following gastric bypass surgery in morbidly obese subjects [J]. Obes Surg, 2006; 16(12): 1594-1601.
|
28. |
Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes [J]. Curr Opin Endocrinol Diabetes Obes, 2008; 15(2): 153-158.
|
29. |
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP [J]. Gastroenterology, 2007; 132(6): 2131-2157.
|
30. |
Drucker DJ. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis [J]. Endocrinology, 2003; 144(12): 5145-5148.
|
31. |
Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery [J]. N Engl J Med, 2005; 353(3): 249-254.
|